Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SNAP vs GSK✓SelectedUSD · GSKSNAP vs GSK performance historyLatest closeAs of+8.06%11/17
Stock and ETF performance explorer

SNAP vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-77.5%
GSK return
+85.7%
Excess return
-163.2%
Maximum drawdown
-95.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+8.1%-2.3%+10.4%+8.6%
7D+10.0%-3.0%+13.0%+10.7%
30D-10.3%+0.4%-10.6%-10.4%
3M+6.2%-1.2%+7.4%+6.4%
6M-0.5%+0.9%-1.5%-1.1%
YTD-31.8%+4.0%-35.8%-33.3%
1Y-32.8%+7.3%-40.1%-34.8%
3Y-53.7%+57.1%-110.8%-61.6%
5Y-89.9%+43.0%-132.9%-91.5%
All-77.5%+85.7%-163.2%-82.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling